Mechanisms of tigecycline resistance among Klebsiella pneumoniae clinical isolates

Antimicrob Agents Chemother. 2014 Nov;58(11):6982-5. doi: 10.1128/AAC.03808-14. Epub 2014 Sep 2.

Abstract

Of 26 tigecycline-nonsusceptible Klebsiella pneumoniae (TNSKP) clinical isolates, 25 had nonsynonymous mutations in ramR and/or acrR (23 in ramR and 10 in acrR). Eight TNSKP isolates possessed overexpression of ramA, acrB, rarA, and oqxB simultaneously, while 8 and 1 TNSKP strains had upregulation of ramA and acrB and of rarA and oqxB, respectively. Thus, resistance mechanisms of 9 TNSKP isolates cannot be explained by the present pathways. This study underscores the role of RamA in TNSKP and suggests the presence of novel tigecycline resistance mechanisms.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Drug Resistance, Multiple, Bacterial / genetics
  • Humans
  • Klebsiella Infections / drug therapy
  • Klebsiella Infections / microbiology
  • Klebsiella pneumoniae / drug effects*
  • Klebsiella pneumoniae / genetics*
  • Klebsiella pneumoniae / isolation & purification
  • Membrane Transport Proteins / genetics*
  • Microbial Sensitivity Tests
  • Minocycline / analogs & derivatives*
  • Minocycline / pharmacology
  • Multidrug Resistance-Associated Proteins / genetics*
  • Tigecycline

Substances

  • AcrR protein, Klebsiella pneumoniae
  • Anti-Bacterial Agents
  • Membrane Transport Proteins
  • Multidrug Resistance-Associated Proteins
  • Tigecycline
  • Minocycline